SynGen Obtains $5,000,000 Series A Financing Round

  • Feed Type
  • Date
    4/20/2012
  • Company Name
    SynGen
  • Mailing Address
    1919 21st Street Sacramento, CA 95811
  • Company Description
    SynGen enables regenerative cures through innovative engineering. We are in the business of inventing and commercializing products that utilizes single-use sterile plastic cartridge disposables and dedicated, highly automated mechanical medical devices to isolate and capture stem and progenitor cells from peripheral and umbilical cord blood, bone marrow, and adipose tissue.
  • Website
    http://www.syngeninc.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $5,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    We will use these proceeds to accelerate the commercialization of our SynGen-1000 platform product.
  • M&A Terms
  • Venture Investor
    Bay City Capital

By posting a comment, you agree to our terms and conditions.